Population-based, real-world prognostic factors related to survival among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).

Yu, KH; Cockrum, P; Surinach, A; Wang, S; Chu, BC

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):